Welcome to our dedicated page for ASE Technology Holding Co., Ltd. SEC filings (Ticker: ASX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ASE Technology Holding Co., Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ASE Technology Holding Co., Ltd.'s regulatory disclosures and financial reporting.
ASE Technology Holding Co., Ltd. reported unaudited consolidated net revenues showing growth in both September and the third quarter of 2025. Consolidated net revenues in September were NT$60,561M ($1,995M), up 7.3% sequentially and 9.0% year‑over‑year in NT$. For the three months ended Q3, consolidated net revenues were NT$168,569M ($5,663M), rising 11.8% sequentially and 5.3% year‑over‑year in NT$; on a US$ basis Q3 revenues increased 17.1% sequentially and 14.3% year‑over‑year. Business segments shown also posted increases: one segment recorded September net revenues of NT$34,997M ($1,153M), up 4.4% sequentially and 20.0% YoY in NT$, while another reported Q3 net revenues of NT$100,289M ($3,371M), up 8.3% sequentially and 16.9% YoY in NT$. The figures are unaudited and presented in both NT$ and US$.
ASE Technology Holding Co., Ltd. disclosed revised unaudited consolidated net revenues for August 2025. The filing reports August net revenues of NT$56,466 million, up 9.6% sequentially from July (NT$51,542m) and 6.7% year-over-year from August 2024 (NT$52,930m). In U.S. dollars the top-line for August was US$1,899 million, up 7.4% sequentially and 16.7% year-over-year. The document also presents a second set of figures showing August net revenues of NT$33,510 million (July NT$31,783m; Aug 2024 NT$29,175m), a 5.4% sequential and 14.9% YoY increase, and corresponding U.S. dollar amounts of US$1,127 million (up 3.3% sequential and 25.7% YoY).
ASE Technology Holding Co., Ltd. reported revised unaudited consolidated net revenues for July 2025 of NT$51,542 million (US$1,769 million). Consolidated revenue rose 4.1% sequentially in NT$ and 6.5% sequentially in US$, while July was essentially flat year-over-year in NT$ (-0.1% YoY) but up 11.2% YoY in US$ versus July 2024. The assembly, testing and materials (ATM) segment generated NT$31,783 million (US$1,091 million), up 3.6% sequentially and 15.8% YoY in NT$ (29.0% YoY in US$). The company notes these figures are revised and unaudited and provided to meet Taiwan regulatory requirements.
ASE Technology (ASX) – Form 6-K, Q2 2025 results. Consolidated revenue reached NT$150.8 bn (+2 % QoQ, +7 % YoY), driven by the core ATM business, which climbed 20 % YoY to NT$91.6 bn and now represents 61 % of sales. EMS declined 7 % YoY to NT$58.4 bn.
Group gross profit improved to NT$25.7 bn with a 17.0 % margin (+20 bp QoQ, +60 bp YoY). Operating income grew 5 % QoQ to NT$10.2 bn (6.8 % margin). Nevertheless, pretax income fell 8 % YoY and net income attributable to shareholders slipped 3 % YoY to NT$7.5 bn; basic EPS was NT$1.74.
Within ATM, testing revenue surged 32 % YoY; leading-edge packaging & testing exceeded 10 % of ATM sales versus 6 % for FY-24. Segment gross margin remained robust at 21.9 % despite a 70 bp sequential easing. EMS margin stayed low at 2.6 % and operating profit dropped 22 % YoY.
Balance sheet: cash fell to NT$72.8 bn while interest-bearing debt rose to NT$240.1 bn, lifting net-debt/equity from 0.41 to 0.52. Capex totaled US$992 m in Q2, outpacing quarterly EBITDA (US$879 m).
Guidance: Management expects Q3 2025 USD revenue to rise 12-14 % QoQ (ATM +9-11 %, EMS +18-20 %), but projects a 1.0-1.2 pp gross-margin decline and a 0.1-0.3 pp operating-margin decline. EMS margin should improve 0.3-0.5 pp.